Apollo Endosurgery Inc. (APEN) Fundamentals

Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focusses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include ORBERA, LAP-BAND and OverStitch.
SHARE INFORMATION
Market CapUS$ 169,454,192
Shares Outstanding40,250,402
Float33,982,367
Percent Float84.43%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 62,989,000
Latest Fiscal EPSUS$ -0.81
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions120
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months5,746,276
Institutional Holdings Percent83.9%
Institutional Sold Previous 3 Months375,401
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months171,763
Insider Holdings Percent9.5
Insider Sold Previous 3 Months-
Insider Shares Owned3,748,855
TRADING INFO
52 Week HighUS$ 10.39
52 Week LowUS$ 3.58
52 Week High ChangeUS$ -39.60
21 Day Moving AverageUS$ 4.6129
21 Day Extended Moving AverageUS$ 4.5168
50 Day Moving AverageUS$ 5.4132
50 Day Extended Moving AverageUS$ 5.1511
200 Day Moving AverageUS$ 7.2762
200 Day Extended Moving AverageUS$ 6.3538
10 Day Average Volume124,209
20 Day Average Volume168,383
30 Day Average Volume139,371
50 Day Average Volume142,914
Alpha-0.006393
Beta2.2665
Standard Deviation0.277646
R20.149323
7 Day Price ChangeUS$ 0.39
7 Day Percent Change10.21%
21 Day Price ChangeUS$ -1.35
21 Day Percent Change-24.28%
30 Day Price ChangeUS$ -1.54
30 Day Percent Change-26.78%
Month to Date Price ChangeUS$ -1.22
Month to Date Percent Change-22.47%
Quarter to Date Price ChangeUS$ -1.84
Quarter to Date Percent Change-30.41%
180 Day Price ChangeUS$ -4.19
180 Day Percent Change-49.88%
200 Day Price ChangeUS$ -5.12
200 Day Percent Change-54.88%
Year to Date Price ChangeUS$ -4.22
Year to Date Percent Change-50.06%

Apollo Endosurgery Inc. (APEN) Key Ratios

PROFITABILITY
EBIT Margin-30.4%
EBITDA Margin-25.8%
Pre-Tax Profit Margin-57.7%
Profit Margin Count-43.47%
Gross Margin56.0%
Profit Margin TOT-43.47%
INCOME STATEMENTS
RevenueUS$ 65,794,000
Revenue Per ShareUS$ 1.6346
Revenue (3 Years)US$ 3.31
Revenue (5 Years)US$ -5.32
FINANCIAL STRENGTH
Price to Tangible Book3.40
Total Debt To Equity1.00
Int Coverage-2.40
Current Ratio7.80
Leverage Ratio3.30
Quick Ratio6.70
Long Term Debt To Capital0.49
VALUATION MEASURES
PE Ratio-4.50
Enterprise ValueUS$ 126,566,543
Price to Sales2.5755
Price to Free Cash-8.80
PE High Last 5 Years-0.20
Price To Book2.80
Price To Cash Flow0.00
PE Low Last 5 Years-3.20
Price to Tangible Book3.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.00
Invoice Turnover2.40
Assets Turnover0.70
Return Assets-29.24
Return on Equity-98.99
Return on Capital-27.83

Apollo Endosurgery Inc. (APEN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMoss Adams LLP
CEOCharles McKhann
Emplyoees202
Last AuditUQ
CIK0001251769
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSSurgical and Medical Instrument Manufacturing(339112)
CONTACT INFO
Address1120 S. Capital of Texas Highway
Building 1, Suite 300
Austin, TX 78746
Websitehttp://www.apolloendo.com
Facsimile+1 512 279-5105
Telephone+1 512 279-5100
Emailinvestor-relations@apolloendo.com
Your Recent History
NASDAQ
APEN
Apollo End..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20220527 00:09:33